AngioDynamics's Enterprise Value for the quarter that ended in Feb. 2024 was $143.5 Mil.
AngioDynamics's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 was $-63.5 Mil. AngioDynamics's Earnings Yield (Joel Greenblatt) for the quarter that ended in Feb. 2024 was -44.25%.
The historical rank and industry rank for AngioDynamics's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ANGO'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -55.58 Med: -2.05 Max: 3.47
Current: -33
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of AngioDynamics was 3.47%. The lowest was -55.58%. And the median was -2.05%.
ANGO's Earnings Yield (Joel Greenblatt) % is ranked worse than 81.96% of 848
companies
in the Medical Devices & Instruments industry
Industry Median: 0.19
vs ANGO: -33.00
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. AngioDynamics's Forward Rate of Return (Yacktman) % for the quarter that ended in Feb. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
AngioDynamics Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for AngioDynamics's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
AngioDynamics Annual Data
Trend
May14
May15
May16
May17
May18
May19
May20
May21
May22
May23
Earnings Yield (Joel Greenblatt) %
-1.56
-44.64
-4.08
-3.78
-13.11
AngioDynamics Quarterly Data
May19
Aug19
Nov19
Feb20
May20
Aug20
Nov20
Feb21
May21
Aug21
Nov21
Feb22
May22
Aug22
Nov22
Feb23
May23
Aug23
Nov23
Feb24
Earnings Yield (Joel Greenblatt) %
-5.53
-13.11
-19.96
-28.41
-44.25
Competitive Comparison
For the Medical Instruments & Supplies subindustry, AngioDynamics's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AngioDynamics Earnings Yield (Joel Greenblatt) % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where AngioDynamics's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
AngioDynamicss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in May. 2023 is calculated as
AngioDynamics's EBIT for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-63.5 Mil.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
AngioDynamics Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of AngioDynamics's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
AngioDynamics (AngioDynamics) Business Description
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANGO has been successfully added to your 